chr4-68565619-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001077.4(UGT2B17):c.826G>T(p.Asp276Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000554 in 1,370,810 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001077.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UGT2B17 | NM_001077.4 | c.826G>T | p.Asp276Tyr | missense_variant | 3/7 | ENST00000317746.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UGT2B17 | ENST00000317746.3 | c.826G>T | p.Asp276Tyr | missense_variant | 3/7 | 1 | NM_001077.4 | P1 | |
UGT2B17 | ENST00000684088.1 | c.76G>T | p.Asp26Tyr | missense_variant | 2/5 |
Frequencies
GnomAD3 genomes AF: 0.00000803 AC: 1AN: 124548Hom.: 0 Cov.: 20
GnomAD3 exomes AF: 0.0000659 AC: 13AN: 197218Hom.: 4 AF XY: 0.0000660 AC XY: 7AN XY: 106038
GnomAD4 exome AF: 0.0000602 AC: 75AN: 1246262Hom.: 19 Cov.: 30 AF XY: 0.0000552 AC XY: 34AN XY: 615786
GnomAD4 genome AF: 0.00000803 AC: 1AN: 124548Hom.: 0 Cov.: 20 AF XY: 0.0000169 AC XY: 1AN XY: 59330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.826G>T (p.D276Y) alteration is located in exon 2 (coding exon 2) of the UGT2B17 gene. This alteration results from a G to T substitution at nucleotide position 826, causing the aspartic acid (D) at amino acid position 276 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at